Genetic screening in new onset inflammatory bowel disease during anti-interleukin 17 therapy: unmet needs and call for action,Expert Opinion on Biological Therapy

当前位置： X-MOL 学术 › Expert Opin. Biol. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Genetic screening in new onset inflammatory bowel disease during anti-interleukin 17 therapy: unmet needs and call for action
Expert Opinion on Biological Therapy ( IF 4.6 ) Pub Date : 2021-08-30 , DOI: 10.1080/14712598.2021.1974395
Carlo Alberto Maronese _{1,

2} , Enrico Zelin ₃ , Chiara Moltrasio _{1,

4} , Giovanni Genovese _{1,

2} , Angelo Valerio Marzano _{1,

2}

Affiliation

(2021). Genetic screening in new onset inflammatory bowel disease during anti-interleukin 17 therapy: unmet needs and call for action. Expert Opinion on Biological Therapy: Vol. 21, No. 12, pp. 1543-1546.

中文翻译：